ElastiMed is developing a compression stocking, made from smart materials, that mimics rhythmic calf muscle contractions and stimulates blood flow.
There is a clear need in the compression therapy market for increased compliance, which improves treatment and prevents symptoms such as swelling, blood clots, and leg ulcers from returning.
ElastiMed is developing a compression stocking, made from smart materials, that mimics rhythmic calf muscle contractions and stimulates blood flow. Based on proprietary technology that utilizes Electro-Active Polymers (EAPs), ElastiMed’s stocking stretches and contracts when stimulated by an electric pulse (generated by a 3V battery).
These unique characteristics, combined with low-cost materials and a high level of control, enable the ElastiMed stocking to provide patients with a highly effective, easy-to-wear, and affordable treatment option. Read more about the idea behind the ElastiMed stocking.
Trendlines’ directors: Todd Dollinger, Shahar Harari
Founded: July 2015
Stage: Technology development
Investors: The Trendlines Group, Pix Vine Capital, private investor, strategic investor
IP: Approved U.S. patent
A 60% noncompliance rate for existing treatment options. Chronic leg swelling (edema), which is caused by poor circulation, affects more than 7.4 million people in the United States alone1. Edema may result from old age, cancer treatments, poor diet or pregnancy. Blood clots, which are formed in the legs (DVT, deep vein thrombosis), affect over 790,000 people in the United States and EU2. Applying constant or changing external pressure on the legs has been proven to be a highly effective treatment to improve circulation and reduce swelling3. With a more than 60% non-compliance4 rate for existing treatment options, ElastiMed’s device is aimed at improving patient compliance with a comfortable, highly effective clinical treatment.
An estimated $3 billion market. ElastiMed addresses a potential global market of $3.3 billion. Leading players include BSN Medical, DJO, Medi, Medtronic, Sigvaris, Tactile Medical.
See ElastiMed on Reuters Video.
Watch Omer Zelka's interview on Start-Up Stadium (Hebrew).
See Omer Zelka's interview on ILTV.
See the company one-page description in Chinese (PDF).
CEO Omer Zelka presents ElastiMed.
ElastiMed's active compression stocking mimics rhythmic calf muscle contractions and stimulates blood flow.
Minimally invasive treatment of heart valve disease
A more efficient ablation catheter to treat atrial fibrillation
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer